You are here
Open
NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.
If no search results for your keyword(s) were found, you are encouraged to review Agency omnibus solicitations for additional funding opportunities. Omnibus solicitations are structured to be broad, extensive Programmatic issuances with research areas related to the petitioning Agency and are not limited to predetermined Topics/Subtopics. If upon reviewing you have additional questions, you may consider reaching out to the respective Agency for clarification regarding acceptable proposals (https://www.sbir.gov/agency-contacts).
-
AF241-D012: Mandatory Declassification Review (MDR) Natural Language Processing (NLP) Tool
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Trusted AI and Autonomy OBJECTIVE: Finding a solution to assist AFDO’s Mandatory Declassification Review (MDR) program in increasing efficiencies, achieving consistency of line-by-line review and redaction of information to remain classified, and promote cost savings through use of new technologies and industry best practices. A successful solution has ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
AF241-D022: Microelectronics Inoculation
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Microelectronics; Space Technology; Integrated Sensing and Cyber OBJECTIVE: The end-state would be a full demonstration of the technology for military use cases. In addition, any tools and process utilized for microelectronics inoculation are fully documented. Develop a plan for scaling the delivery of the solution to military and commercial systems. ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
SF241-0018: Mitigating Negative Effects of Polysulfide Dissolution in 18650 Lithium Sulfur Battery
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Trusted AI and Autonomy; Microelectronics; Space Technology; Renewable Energy Generation and Storage; Advanced Materials OBJECTIVE: The objective of this topic is to improve cycle life and capacity retention of Lithium-Sulfur battery chemistry by addressing and resolving negative effects of parasitic polysulfide reactions. DESCRIPTION: The current st ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
AF241-0006: Mobile Target Tracking
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024<add> AF241-0006 DOD SBIR 24.1 BAA Department of Defense Air Force ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
SF241-0025: Modernizing USSF BMT
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Human-Machine Interfaces The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120-130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Export Administration Regulation (EAR), 15 CFR Parts 730-774, which con ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)
Release Date: 08-31-2021Open Date: 11-09-2021 Due Dates: Multiple Close Date: 12-10-2023The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women. Applications for MPT development may involve pharmacokinetic (PK) ...
SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
PAR-21-298: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)
Release Date: 08-31-2021Open Date: 11-09-2021 Due Dates: Multiple Close Date: 12-10-2023Purpose The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women. Applications for MPT development may involve pharmacokin ...
STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
SF241-0014: MUOS SATCOM Simulator Connectivity Over IP
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024SF241-0014 DOD SBIR 24.1 BAA Department of Defense Air Force ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
PAR-21-224: NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Release Date: 05-05-2021Open Date: 08-05-2021 Due Dates: Multiple Close Date: 04-06-2024Purpose: To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies, NINDS has formed the Neurology Network of Excellence in Clinical Trials (NeuroNEXT, www.NeuroNEXT.org). NeuroNEXT has a Clinical Coordinating Center (C ...
SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
RFA-HL-23-009: NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
Release Date: 11-16-2021Open Date: 01-28-2022 Due Dates: Multiple Close Date: 02-29-2024Since its inception in 1982, the NIH SBIR program has provided the small business community with seed funding to support the development of a broad array of commercial products to detect, diagnose, treat, and prevent disease. It provides an important funding mechanism for bringing new interventions to patients and clinicians. The SBIR program is structured in three phases. The objective in Phase I ...
SBIRPhase IIDepartment of Health and Human ServicesNational Institutes of Health